Fidelity Investments
ABEO icon

Fidelity Investments’s Abeona Therapeutics ABEO Stock Holding History

Fidelity Investments’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$218K Sell
41,457
-97,040
-70% -$602K ﹤0.01% 3662
2026
Q2 		$856K Sell
138,497
-56,316
-29% -$309K ﹤0.01% 3068
2026
Q1 		$873K Buy
194,813
+26,358
+16% +$132K ﹤0.01% 2924
2025
Q4 		$888K Buy
168,455
+162,671
+2,812% +$819K ﹤0.01% 2895
2025
Q3 		$30.5K Sell
5,784
-1,296
-18% -$8.22K ﹤0.01% 4181
2025
Q2 		$40.2K Buy
+7,080
New +$40.3K ﹤0.01% 3995
2024
Q2 		– Sell
-40
Closed -$290 – 5347
2024
Q1 		$290 Buy
+40
New +$253 ﹤0.01% 4891
2023
Q3 		– Sell
-16
Closed -$64 – 5266
2023
Q2 		$64 Buy
+16
New +$56 ﹤0.01% 4996
2019
Q4 		– Sell
-29,367
Closed -$1.66M – 3737
2019
Q3 		$1.66M Sell
29,367
-140,077
-83% -$10.5M ﹤0.01% 2311
2019
Q2 		$20.2M Sell
169,444
-118,171
-41% -$19.8M ﹤0.01% 1618
2019
Q1 		$52.9M Sell
287,615
-52
-0% -$9.3K 0.01% 1191
2018
Q4 		$51.3M Buy
287,667
+7
+0% +$1.53K 0.01% 1123
2018
Q3 		$92.1M Buy
287,660
+3,888
+1% +$1.38M 0.01% 988
2018
Q2 		$114M Buy
283,772
+91,640
+48% +$40M 0.01% 893
2018
Q1 		$68.9M Buy
192,132
+35,988
+23% +$13.4M 0.01% 1150
2017
Q4 		$61.9M Buy
+156,144
New +$64.6M 0.01% 1196

Other funds holding ABEO

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
AIC
AWM Investment Company New York $1.04B AUM 103.31% 1-Year Est. Return
Kennedy Capital Management
Kennedy Capital Management St Louis, Missouri $5.31B AUM 40.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Fidelity Investments's ABEO Position: Q3 2026 in Review

Fidelity Investments reduced its Abeona Therapeutics (ABEO) stake by 70% in Q3 2026, selling an estimated $602K and leaving 41,457 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #3662.

Fidelity Investments first reported a position in ABEO in Q4 2017 and has held it in 16 quarters since. The position peaked at $114M in Q2 2018. 74 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

  • Fidelity Investments held 41,457 shares of Abeona Therapeutics worth $218K as of Q3 2026.
  • Fidelity Investments sold 97,040 Abeona Therapeutics shares in Q3 2026, an estimated $602K.
  • Abeona Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #3662 holding.
  • Fidelity Investments first reported a position in Abeona Therapeutics in Q4 2017 and has held it in 16 quarters since.
  • Fidelity Investments's Abeona Therapeutics position peaked at $114M in Q2 2018.
  • 74 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.